Iohexol
FDA Approved: * November 13, 2025Pharm Company: * AMNEAL
Category: Diagnostic Aid
Iohexol, sold under the trade name Omnipaque among others, is a contrast agent used for X-ray imaging.[1] This includes when visualizing arteries, veins, ventricles of the brain, the urinary system, and joints, as well as during computed tomography (CT scan).[1] It is given by mouth, injection into a vein, or into a body cavity.[2] Side effects include vomiting, skin flushing, headache, itchiness, kidney problems, and low blood pressure.[... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Iohexol 300 mg/ml Intra-articular; Intrathecal; Intravascular; Intravenous; Oral; Rectal Injection, Solution
NDC: 80830-2467
Labeler:
Amneal Pharmaceuticals Private Limited
Iohexol 300 mg/ml Intra-articular; Intrathecal; Intravascular; Intravenous; Oral; Rectal Injection, Solution
NDC: 80830-2468
Labeler:
Amneal Pharmaceuticals Private Limited
